首页|LncRNA HAND2-AS1在宫颈癌患者血清中的表达及临床意义

LncRNA HAND2-AS1在宫颈癌患者血清中的表达及临床意义

扫码查看
目的 探究长链非编码RNA(LncRNA)心脏和神经嵴衍生物表达转录本2反义序列1(HAND2-AS1)在宫颈癌患者血清中的表达及其临床意义。方法 选取2019年1月至2020年6月焦作市妇幼保健院收治的50例宫颈癌患者作为宫颈癌组,并根据中位lncRNA HAND-AS1表达值分为lncRNA HAND-AS1高表达组和lncRNA HAND-AS1低表达组,每组25例;选取同期确诊的50例宫颈上皮内瘤变(CIN)患者作为CIN组和50例健康体检者作为健康对照组。采用实时荧光定量聚合酶链反应技术和电化学发光法检测各组研究对象血清lncRNA HAND2-AS1表达水平,以及癌抗原125(CA125)和鳞状细胞癌相关抗原(SCC)水平,分析其与患者临床特征和预后的关系。绘制受试者工作特征(ROC)曲线分析血清lncRNA HAND2-AS1、CA125、SCC联合检测对宫颈癌的临床诊断效能。结果 宫颈癌组患者血清LncRNA HAND2-A S1表达水平均明显低于CIN组和健康对照组,其表达水平与宫颈癌患者肿瘤长径、宫颈浸润深度、国际妇产科联盟(FIGO)分期和淋巴结转移明显相关,差异均有统计学意义(P<0。05)。lncRNA HAND2-AS1单独诊断宫颈癌的ROC曲线下面积为0。861(95%可信区间0。792~0。930),HAND2-AS1、CA125、SCC联合诊断宫颈癌的ROC曲线下面积为0。912(95%可信区间0。908~0。952),诊断效能明显高于单指标检测,差异均有统计学意义(P<0。05)。lncRNA HAND-AS1高表达组患者3年生存率明显高于lncRNA HAND-AS1低表达组,差异有统计学意义(P<0。05)。LncRNA HAND2-AS1、CA12 5、SCC、FIGO分期、淋巴结转移与宫颈癌患者预后相关,差异均有统计学意义(P<0。05);FIGO分期、SCC是影响宫颈癌患者预后的独立危险因素,差异均有统计学意义(P<0。05)。结论 LncRNA HAND2-AS1在宫颈癌患者血清中低表达,并与患者肿瘤长径、宫颈浸润深度、FIGO分期、淋巴结转移均明显相关;检测血清lncRNA HAND2-AS1对宫颈癌的诊断及预后评估具有一定价值。
Expression and clinical significance of LncRNA HAND2-AS1 in serum of patients with cervical cancer
Objective To investigate the expression and clinical significance of long non-coding RNA(lncRNA)heart and neural crest derivatives express transcript 2 antisense sequence 1(HAND2-AS1)in ser-um of patients with cervical cancer.Methods A total of 50 patients with cervical cancer admitted to Maternal and Child Health Hospital of Jiaozuo City from January 2019 to June 2020 were selected as the cervical cancer group,and were divided into lncRNA HAND-AS1 high expression group and lncRNA HAND-AS1 low ex-pression group according to the median lncRNA HAND-AS1 expression value,with 25 cases in each group.During the same period,55 patients with cervical intraepithelial neoplasia(CIN)diagnosed were selected as CIN group and 50 healthy subjects were selected as healthy control group.Real-time fluorescence quantitative polymerase chain reaction and electrochemiluminescence were used to detect the expression of serum lncRNA HAND2-AS1,cancer antigen 125(CA125)and squamous cell carcinoma-associated antigen(SCC)in each group,and their relationship with clinical characteristics and prognosis was analyzed.The receiver operating characteristic(ROC)curve was drawn to analyze the clinical diagnostic efficacy of combined detection of ser-um lncRNA HAND2-AS1,CA125 and SCC in cervical cancer.Results The expression of serum lncRNA HAND2-AS1 in cervical cancer group was significantly lower than that in CIN group and healthy control group.The expression level of LncRNA HAND2-AS1 was significantly correlated with tumor size,cervical in-filtration depth,FIGO stage and lymph node metastasis in cervical cancer patients(P<0.05).The area under the ROC curve of lncRNA HAND2-AS1 in the diagnosis of cervical cancer was 0.861(95%CI 0.792-0.930).The area under the ROC curve of HAND2-AS1,CA125 and SCC in the diagnosis of cervical cancer was 0.912(95%CI 0.908-0.952).The diagnostic efficiency was significantly higher than that of single index detection,and the difference was statistically significant(P<0.05).The 3-year survival rate of patients in ln-cRNA HAND-AS1 high expression group was significantly higher than that in lncRNA HAND-AS1 low ex-pression group,and the difference was statistically significant(P<0.05).LncRNA HAND2-AS1,CA125,SCC,FIGO stage and lymph node metastasis were related to the prognosis of patients with cervical cancer,and the differences were statistically significant(P<0.05).FIGO stage and SCC were independent risk factors af-fecting the prognosis of patients with cervical cancer,and the differences were statistically significant(P<0.05).Conclusion The expression of LncRNA HAND2-AS1 in serum of patients with cervical cancer is low,which is obviously correlated with tumor size,depth of cervical invasion,FIGO stage and lymph node metastasis.Detection of serum lncRNA HAND2-AS1 has certain value in the diagnosis and prognosis evaluation of cervical cancer.

Cervical cancerLong non-coding RNAHeart and neural crest derivatives express transcript 2 antisense sequence 1PrognosisRisk factors

张晓科、褚艳荣、崔发财

展开 >

焦作市妇幼保健院检验科,河南焦作 454000

焦作市妇幼保健院妇产科,河南焦作 454000

河南省人民医院检验科,河南 郑州 450000

宫颈肿瘤 长链非编码RNA 心脏和神经嵴衍生物表达转录本2反义序列1 预后 危险因素

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(9)
  • 21